Keyphrases
Adverse Events
10%
AIDS/HIV
100%
Antiretroviral Agents
60%
Antiretroviral Exposure
100%
Baseline Renal Function
100%
Chronic Kidney Disease
20%
Chronic Renal Impairment
20%
Confidence Interval
70%
Consecutive Measurement
10%
D Study
100%
Discontinuation Rate
10%
Disease Incidence
10%
Donor-acceptor
100%
Estimated Glomerular Filtration Rate
100%
Follow-up Interval
10%
Incidence Rate
70%
Kidney Disease Progression
10%
Normal Baselines
100%
Normal Renal Function
10%
Poisson Regression
10%
Rate Measurement
10%
Renal Impairment
100%
Renal Intervention
10%
Ritonavir-boosted Darunavir
40%
Significant Predictors
20%
Tenofovir
40%
Medicine and Dentistry
Adverse Event
10%
Antiretrovirus Agent
60%
Atazanavir
20%
Chronic Kidney Disease
30%
Deterioration
10%
Glomerular Filtration Rate
100%
Human Immunodeficiency Virus
100%
Kidney Function
100%
Lopinavir
20%
Morbidity
10%
Ritonavir
40%
Study Participant
10%
Tenofovir
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
16%
Antiretrovirus Agent
100%
Atazanavir
33%
Chronic Kidney Failure
50%
Deterioration
16%
HIV
100%
Lopinavir
33%
Morbidity
16%
Ritonavir
66%
Tenofovir
66%
INIS
comparative evaluations
10%
disease incidence
10%
diseases
20%
filtration
100%
humans
100%
interventions
10%
kidneys
100%
range
10%
values
10%
viruses
100%